Form D — Entact Bio, Inc.
0000905148-26-002800 · filed Jun 3, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $9,999,997
- Reported amount sold
- $9,999,997
- Minimum investment
- $0
- Investors
- 7
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Entact Bio, Inc.
- CIK
- 2008244
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2021
- Address
- 65 Grove Street, Suite 303
Watertown, MA 02472 - Phone
- 617-909-7579
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Victoria Richon · Executive OfficerWatertown, MA Find on LinkedIn ↗
-
Owen Smith · DirectorWatertown, MA Find on LinkedIn ↗
-
Pini Orbach · DirectorWatertown, MA Find on LinkedIn ↗
-
Andrew Sinclair · DirectorWatertown, MA Find on LinkedIn ↗
-
Richard Gaster · DirectorWatertown, MA Find on LinkedIn ↗
-
Anna French · DirectorWatertown, MA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗